Oxidoreductases monoamine oxidase

Ubiquitous mitochondrial monoamine oxidase [monoamine oxygen oxidoreductase (deaminating) (flavin-containing) EC 1.4.3.4 MAO] exists in two forms, namely type A and type B [ monoamine oxidase (MAO) A and B]. They are responsible for oxidative deamination of primary, secondary, and tertiary amines, including neurotransmitters, adrenaline, noradrenaline, dopamine (DA), and serotonin and vasoactive amines, such as tyramine and phenylethylamine. Their nonselec-tive and selective inhibitors ( selective MAO-A and -B inhibitors) are employed for the treatment of depressive illness and Parkinson s disease (PD). 

The reactions presented here must not be confused with oxidative reactions that increase bond order and are catalyzed by oxidoreductases, as discussed elsewhere. Examples of the latter reactions include the cytochrome P450 mediated oxidation of testosterone to 6,7-dehydrotestosterone, and the oxidation of l,2,3,6-tetrahydro-l-methyl-4-phenylpyridine to 2,3-dihydro-1-methy 1-4-phenylpyridinium catalyzed by monoamine oxidase (Chapt. 4 and 9 in [50]). 

Other oxidoreductases that can play a major or less important role in drug metabolism are hemoglobin, monoamine oxidases (EC 1.4.3.4 MAO-A and MAO-B), which are essentially mitochondrial enzymes, the cytosolic molybdenum hydroxylases (xanthine oxidase, EC 1.1.3.22 xanthine dehydrogenase, EC 1.1.1.204 and aldehyde oxidase, EC 1.2.3.1), d the broad group of copper-containing amine oxidases (EC 1.4.3.6) (36-39). 

Besides the monooxygenases discussed above, a number of other oxidoreductases can oxidize xenobiotics. These enzymes are mostly but not exclusively nonmicrosomal, being present in the cytosol or mitochondria of the liver and extrahepatic tissues. The list includes alcohol dehydrogenases, aldehyde dehydrogenases, dihydrodiol dehydrogenases, haemoglobin, monoamine oxidases, xanthine oxidase and aldehyde oxidase. Some of these enzyme systems are discussed below. 

---